and Viral Load must be recorded within six months from the time of the application;
Retained in care according to the US Health and Human Services (HHS) definition meant having at least one CD4 count
or viral load test in each 6-month period of a 24-month period, with at least 60 days between tests in two 6-month periods
Every doubling of the latest CD4 count
had no impact on the rate of fatal or nonfatal cardiovascular events (adjusted hazard ratio 1.
neoformans infections among HIV patients on HAART, as well as the effect of age, gender and CD4 count
on this prevalence.
In HIV infected patients with CD4 count
< 200 cells/[micro]l, C.
They revealed that the adverse effects of delaying therapy were directly linked to the drop in the CD4 count
Baseline investigations revealed a CD4 count
of 110 cells/[mm.
In the WIHS study published this year, risk factors for condylomas identified among HIV-positive women were cytologic abnormalities, HPV, smoking, no HAART (highly active antiretroviral therapy), and a low CD4 count
In contrast, no one who began treatment with a CD4 count
above 500 cells/[micro]L has had to recommence therapy during 20 months of follow-up.
The typical CD4 count
for a healthy individual is between 500-1500 cells/ml2.
1 But people with a CD4 count
below 200 when they start antiretroviral therapy have a lower expected age at death than people in the general population.
As the CD4 count
begins to drop, an infected person may develop thrush, oral hairy leukoplakia, herpes zoster (shingles), or idiopathic thrombocytopenic purpura.